InMed Pharmaceuticals (INM) Cash & Current Investments: 2021-2025
Historic Cash & Current Investments for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $9.4 million.
- InMed Pharmaceuticals' Cash & Current Investments rose 67.84% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year decrease of 2.11%. This contributed to the annual value of $11.1 million for FY2025, which is 68.10% up from last year.
- Latest data reveals that InMed Pharmaceuticals reported Cash & Current Investments of $9.4 million as of Q3 2025, which was down 15.08% from $11.1 million recorded in Q2 2025.
- In the past 5 years, InMed Pharmaceuticals' Cash & Current Investments registered a high of $15.4 million during Q3 2021, and its lowest value of $3.5 million during Q4 2024.
- For the 3-year period, InMed Pharmaceuticals' Cash & Current Investments averaged around $7.6 million, with its median value being $7.6 million (2024).
- Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 63.04% in 2024, then skyrocketed by 68.10% in 2025.
- Quarterly analysis of 5 years shows InMed Pharmaceuticals' Cash & Current Investments stood at $11.3 million in 2021, then climbed by 1.50% to $11.5 million in 2022, then decreased by 16.67% to $9.6 million in 2023, then slumped by 63.04% to $3.5 million in 2024, then spiked by 67.84% to $9.4 million in 2025.
- Its Cash & Current Investments was $9.4 million in Q3 2025, compared to $11.1 million in Q2 2025 and $4.7 million in Q1 2025.